Hyperuricemia and Blood Lipid Levels in Chronic Myelogenous Leukemia

Number of epidemiologic studies has been published in recent year showing an increased risk of death in cancer with lipid abnormality. In the present study, chronic myelogenous leukemia (CML) patients (age 69±7.23 years) with hyperuricemia and healthy controls (age 67±6.93 years) in Sir J.J. Group of Govt. Hospitals, Mumbai displayed significant (p<0.05) difference in serum cholesterol, HDL and LDL cholesterol and triglycerides levels. The results of the study suggest cost effective, usefulness of these blood lipids in patients with CML for undiagnosed stages of cancer.